These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28687736)

  • 41. Follicular variant of papillary thyroid carcinoma with B-type Raf(V600E) showing higher frequency of suspicious sonographic features and multifocality.
    Shin DY; Kim KJ; Chang S; Kim H; Hwang S; Kim W; Bae J; Park S; Kang SW; Chung WY; Lee EJ
    Head Neck; 2015 Nov; 37(11):1590-5. PubMed ID: 24909403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center.
    Lim JY; Hong SW; Lee YS; Kim BW; Park CS; Chang HS; Cho JY
    Thyroid; 2013 Nov; 23(11):1423-30. PubMed ID: 23496275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of the effect of Hashimoto's thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer.
    Tan HL; Nyarko A; Duan SL; Zhao YX; Chen P; He Q; Zhang ZJ; Chang S; Huang P
    Front Endocrinol (Lausanne); 2022; 13():987906. PubMed ID: 36714580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.
    Wang F; Zhao S; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Xing M
    J Clin Oncol; 2018 Sep; 36(27):2787-2795. PubMed ID: 30070937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sonographic characteristics and clinical characteristics combined with nomogram for predicting the aggressiveness of papillary thyroid carcinoma coexisted with Hashimoto's thyroiditis.
    Zhao S; Zhang Z; Zhang X; Wu X; Chen Y; Min X; Chen B
    Braz J Otorhinolaryngol; 2024; 90(5):101456. PubMed ID: 38968750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive Value of BRAF
    Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J
    Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Diagnosis of High-Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAF
    Xie F; Yan L; Li YM; Lan Y; Xiao J; Zhang MB; Jin Z; Zhang Y; Tian XQ; Zhu YQ; Li ZP; Luo YK
    J Ultrasound Med; 2022 Nov; 41(11):2789-2802. PubMed ID: 35229905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography.
    Agyekum EA; Wang YG; Xu FJ; Akortia D; Ren YZ; Chambers KH; Wang X; Taupa JO; Qian XQ
    Sci Rep; 2023 Aug; 13(1):12604. PubMed ID: 37537230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.
    Kim MH; Bae JS; Lim DJ; Lee H; Jeon SR; Park GS; Jung CK
    Endocr Relat Cancer; 2014; 21(6):891-902. PubMed ID: 25266729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of
    Kure S; Ishino K; Kudo M; Wada R; Saito M; Nagaoka R; Sugitani I; Naito Z
    J Int Med Res; 2019 Nov; 47(11):5560-5572. PubMed ID: 31533501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Papillary thyroid carcinoma with BRAFV600E mutation: sonographic prediction.
    Hwang J; Shin JH; Han BK; Ko EY; Kang SS; Kim JW; Chung JH
    AJR Am J Roentgenol; 2010 May; 194(5):W425-30. PubMed ID: 20410389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles.
    Moon WJ; Choi N; Choi JW; Kim SK; Hwang TS
    AJR Am J Roentgenol; 2012 Mar; 198(3):668-74. PubMed ID: 22358007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse.
    Renaud F; Gnemmi V; Devos P; Aubert S; Crépin M; Coppin L; Ramdane N; Bouchindhomme B; d'Herbomez M; Van Seuningen I; Do Cao C; Pattou F; Carnaille B; Pigny P; Wémeau JL; Leteurtre E
    Thyroid; 2014 Sep; 24(9):1375-84. PubMed ID: 25012490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of immunohistochemistry to detect BRAF V600E mutant protein in thyroid tissues.
    Zhang Y; Liu L; Liu Y; Cao N; Wang L; Xing C
    Medicine (Baltimore); 2021 Apr; 100(16):e25566. PubMed ID: 33879712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes.
    Watutantrige-Fernando S; Vianello F; Barollo S; Bertazza L; Galuppini F; Cavedon E; Censi S; Benna C; Ide EC; Parisi A; Nacamulli D; Iacobone M; Pennelli G; Mian C
    Thyroid; 2018 Jan; 28(1):96-103. PubMed ID: 29179638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas.
    Chuang TC; Chuang AY; Poeta L; Koch WM; Califano JA; Tufano RP
    Head Neck; 2010 Feb; 32(2):229-34. PubMed ID: 19626635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on
    Chen J; Li XL; Zhang YF; Wang D; Wang Q; Zhao CK; Li MX; Wei Q; Ji G; Xu HX
    Future Oncol; 2020 Aug; 16(22):1607-1618. PubMed ID: 32501726
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAF(V600E) Mutation and BRAF Pseudogene.
    Lin JD; Fu SS; Chen JY; Lee CH; Chau WK; Cheng CW; Wang YH; Lin YF; Fang WF; Tang KT
    Thyroid; 2016 May; 26(5):691-704. PubMed ID: 26914762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.